Advertisement
Canada markets closed

  • S&P/TSX

    22,259.16
    -31.46 (-0.14%)
     

  • S&P 500

    5,187.67
    -0.03 (-0.00%)
     

  • DOW

    39,056.39
    +172.13 (+0.44%)
     

  • CAD/USD

    0.7284
    -0.0004 (-0.05%)
     

  • CRUDE OIL

    79.37
    +0.38 (+0.48%)
     

  • Bitcoin CAD

    84,627.66
    -1,583.26 (-1.84%)
     

  • CMC Crypto 200

    1,313.39
    +18.72 (+1.45%)
     

  • GOLD FUTURES

    2,317.30
    -5.00 (-0.22%)
     

  • RUSSELL 2000

    2,055.14
    -9.51 (-0.46%)
     

  • 10-Yr Bond

    4.4920
    +0.0290 (+0.65%)
     

  • NASDAQ futures

    18,161.50
    -25.00 (-0.14%)
     

  • VOLATILITY

    13.00
    -0.23 (-1.74%)
     

  • FTSE

    8,354.05
    +40.38 (+0.49%)
     

  • NIKKEI 225

    38,392.10
    +189.73 (+0.50%)
     

  • CAD/EUR

    0.6775
    -0.0001 (-0.01%)
     

Valeant won't pay whatever it takes for Allergan: CEO

Reuters

(Reuters) - Valeant Pharmaceuticals Inc won't pay whatever it takes to acquire rival Allergan Inc, and it will not turn its bid into an all-cash deal, Valeant Chief Executive Michael Pearson said on Tuesday in New York. Valeant and activist investor Bill Ackman made an unsolicited $47 billion bid to buy Botox maker Allergan as it seeks to become one of the world's five biggest drug companies. (Reporting by Bill Berkrot in New York; Writing by Rod Nickel in Winnipeg, Manitoba; Editing by Meredith Mazzilli)